Controlled Trial of Pretest Education Approaches to Enhance Informed Decision-Making for BRCA1 Gene Testing
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In response to the isolation of the BRCA1 gene, a breast-ovarian cancer-susceptibility gene, biotechnology companies are already marketing genetic tests to health care providers and to the public. Initial studies indicate interest in BRCA1 testing in the general public and in populations at high risk. However, the optimal strategies for educating and counseling individuals have yet to be determined. PURPOSE: Our goal was to evaluate the impact of alternate strategies for pretest education and counseling on decision-making regarding BRCA1 testing among women at low to moderate risk who have a family history of breast and/or ovarian cancer. METHODS: A randomized trial design was used to evaluate the effects of education only (educational approach) and education plus counseling (counseling approach), as compared with a waiting-list (control) condition (n = 400 for all groups combined). The educational approach reviewed information about personal risk factors, inheritance of cancer susceptibility, the benefits, limitations, and risks of BRCA1 testing, and cancer screening and prevention options. The counseling approach included this information, as well as a personalized discussion of experiences with cancer in the family and the potential psychological and social impact of testing. Data on knowledge of inherited cancer and BRCA1 test characteristics, perceived risk, perceived benefits, limitations and risks of BRCA1 testing, and testing intentions were collected by use of structured telephone interviews at baseline and at 1-month follow-up. Provision of a blood sample for future testing served as a proxy measure of intention to be tested (in the education and counseling arms of the study). The effects of intervention group on study outcomes were evaluated by use of hierarchical linear regression modeling and logistic regression modeling (for the blood sample outcome). All P values are for two-sided tests. RESULTS: The educational and counseling approaches both led to significant increases in knowledge, relative to the control condition (P < .001 for both). The counseling approach, but not the educational approach, was superior to the control condition in producing significant increases in perceived limitations and risks of BRCA1 testing (P < .01) and decreases in perceived benefits (P < .05). However, neither approach produced changes in intentions to have BRCA1 testing. Prior to and following both education only and education plus counseling, approximately one half of the participants stated that they intended to be tested; after the session, 52% provided a blood sample. CONCLUSIONS: Standard educational approaches may be equally effective as expanded counseling approaches in enhancing knowledge. Since knowledge is a key aspect of medical decision-making, standard education may be adequate in situations where genetic testing must be streamlined. On the other hand, it has been argued that optimal decision-making requires not only knowledge, but also a reasoned evaluation of the positive and negative consequences of alternate decisions. Although the counseling approach is more likely to achieve this goal, it may not diminish interest in testing, even among women at low to moderate risk. Future research should focus on the merits of these alternate approaches for subgroups of individuals with different backgrounds who are being counseled in the variety of settings where BRCA1 testing is likely to be offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1980) · Medical Entomology and Zoology · Cited by 25,810
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Decision making: A psychological analysis of conflict, choice, and commitment
(1978) · Evaluation and Program Planning · doi:10.1016/0149-7189(78)90042-3 · Cited by 3,946
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Four Models of the Physician-Patient Relationship
Emanuel, E. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160079038 · Cited by 2,449
Birth Defects: Original Article Series.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-157_8 · Cited by 1,387
Lerman, C. (1996) · JAMA · doi:10.1001/jama.1996.03530480027036 · Cited by 792
Self-citationRecruiting Minorities Into Clinical Trials Toward a Participant-Friendly System
Swanson, G. M., & Ward, A. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.23.1747 · Cited by 554
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.843 · Cited by 523
Self-citationEffects of Individualized Breast Cancer Risk Counseling: a Randomized Trial
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., & Balshem, A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.286 · Cited by 435
Self-citationInterest in genetic testing among first‐degree relatives of breast cancer patients
Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320570304 · Cited by 329
Self-citationShattuck-Eidens, D. (1995) · JAMA · doi:10.1001/jama.1995.03520310033026 · Cited by 246
Genetic Counseling: A Consumers' View
Leonard, C. O., Chase, G. A., & Childs, B. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208312870904 · Cited by 216
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Struewing, J. P., Lerman, C., Kase, R. G., Giambarresi, T. R., & Tucker, M. A. (1995) · PubMed · Cited by 214
Self-citationEthnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk
Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., & Lerman, C. (1997) · Patient Education and Counseling · doi:10.1016/s0738-3991(97)00064-5 · Cited by 194
Self-citationRl, S. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82652-7 · Cited by 159
Psychosocial factors in bone marrow transplantation: a review and recommendations for research.
Andrykowski, M. A. (1994) · PubMed · Cited by 138
Genetic counseling: Provision and reception of information
Lippman-Hand, A., & Fraser, F. C. (1979) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320030202 · Cited by 138
Decision Making: A Psychological Analysis of Conflict
Aldag, R. J., Janis, I. L., & Mann, L. (1980) · Academy of Management Review · doi:10.5465/amr.1980.4288953 · Cited by 131
Vlek, C. A. J. (1987) · PubMed · Cited by 45
Cited by
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Col, N. F., Bennett, C. L., Barry, M. J., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub4 · Cited by 1,471
Decision aids for patients facing health treatment or screening decisions: systematic review
O'Connor, A. M., Rostom, A., Fiset, V., Tetroe, J., Entwistle, V., Llewellyn-Thomas, H., Holmes-Rovner, M., Barry, M., & Jones, J. (1999) · BMJ · doi:10.1136/bmj.319.7212.731 · Cited by 873
Decision aids for people facing health treatment or screening decisions
Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Légaré, F., & Thomson, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub3 · Cited by 849
Metadata
- Authors
- Lerman, C., Kerner, J., Gomez-Caminero, A., Hughes, C., Reed, M. M., Biesecker, B., & Benkendorf, J. L.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-15
- Volume
- 89
- Issue
- 2
- Pages
- 148-157
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2019634517
- Cited by
- 355
- References
- 20
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.